Precision Optics Corporation (NASDAQ: POCI) completed a priced underwritten public offering of 2,777,777 shares of its common stock at $3.60 per share, raising approximately $10 million before underwriting discounts and commissions. The offering was managed by Lucid Capital Markets and was filed under a shelf registration statement on Form S‑3 that became effective on June 14, 2024.
The company said the net proceeds will be used for working capital and general corporate purposes, including funding growth initiatives and strengthening its balance sheet. The move follows a period of ongoing operating losses and a modest gross profit margin of 9.7 % over the last twelve months, prompting the need for additional liquidity.
Precision Optics has reported revenue growth of 31 % and 30.69 % in the most recent two fiscal years, but has continued to post losses and a negative profit margin. The company’s business spans medical and defense/aerospace optical instruments, and it has historically relied on equity issuances to support capital needs.
Executives participated in the offering, purchasing shares at the offering price, which signals management confidence in the company’s valuation and future prospects. The offering was oversubscribed, reflecting investor interest in the company’s growth strategy.
The pricing of the offering on March 27, 2026 followed the March 26 announcement, and the transaction is expected to close on or about March 30, 2026.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.